LifeStance Health Group, Inc. (LFST)
USD 7.09
(-5.21%)
USD 7.09
(-5.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.05 Billion | 859.54 Million | 667.51 Million | 377.21 Million | 212.51 Million |
| Cost of Revenue | 753.56 Million | 622.52 Million | 466 Million | 242.89 Million | 150.12 Million |
| Gross Profit | 302.09 Million | 237.01 Million | 201.5 Million | 134.32 Million | 62.39 Million |
| Operating Expenses | 491.23 Million | 447.19 Million | 487.86 Million | 330.73 Million | 47.15 Million |
| Selling, General and Administrative Expenses | 410.79 Million | 377.99 Million | 433.72 Million | 330.73 Million | 41.06 Million |
| Research and Development Expenses | - | - | - | - | - |
| Other Expenses | 80.43 Million | 69.19 Million | 54.13 Million | - | 6.09 Million |
| Cost and Expenses | 1.24 Billion | 1.06 Billion | 953.86 Million | 361.78 Million | 197.27 Million |
| Operating Income | -189.13 Million | -210.17 Million | -286.35 Million | 15.43 Million | 15.24 Million |
| Interest Expense | 21.22 Million | 19.92 Million | 38.91 Million | 22.13 Million | 5.4 Million |
| Income Tax Expense | -20.32 Million | -17.16 Million | -25.9 Million | -6.34 Million | 2.2 Million |
| Earnings before Tax | -206.58 Million | -232.73 Million | -333.1 Million | -44.41 Million | 7.87 Million |
| Net Income | -186.26 Million | -215.56 Million | -307.19 Million | -38.07 Million | 5.66 Million |
| Earnings Per Share Basic | -0.51 | -0.61 | -0.94 | -0.10 | 0.02 |
| Earnings Per Share Diluted | -0.51 | -0.61 | -0.94 | -0.10 | 0.02 |
| Weighted Average Shares Outstanding | 367.45 Million | 355.27 Million | 327.52 Million | 373.64 Million | 373.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 367.45 Million | 355.27 Million | 327.52 Million | 373.64 Million | 373.64 Million |
| Gross Margin | 0.29 | 0.28 | 0.30 | 0.36 | 0.29 |
| EBIT Margin | -0.10 | -0.16 | -0.35 | 0.12 | 0.10 |
| Profit Margin | -0.18 | -0.25 | -0.46 | -0.10 | 0.03 |
| EBITDA | -104.92 Million | -136.41 Million | -229.62 Million | 8.76 Million | 21.33 Million |
| Earnings Before Tax Margin | -0.18 | -0.24 | -0.43 | 0.04 | 0.07 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 312.33 Million | 300.43 Million | 280.6 Million | 1.05 Billion | 262.89 Million | 259.57 Million |
| Cost of Revenue | 233.12 Million | 228.27 Million | 219.5 Million | 834 Million | 186.68 Million | 186.6 Million |
| Gross Profit | 79.2 Million | 72.16 Million | 61.09 Million | 221.65 Million | 76.2 Million | 72.97 Million |
| Operating Expenses | 94.77 Million | 88.83 Million | 92.38 Million | 409 Million | 150.56 Million | 121.38 Million |
| Selling, General and Administrative Expenses | 94.77 Million | 88.83 Million | 92.38 Million | - | 130.94 Million | 101.85 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -4000.00 | -74 Thousand | -42 Thousand | -112 Thousand | -1000.00 | -24 Thousand |
| Cost and Expenses | 327.89 Million | 317.11 Million | 311.89 Million | 1.24 Billion | 337.25 Million | 307.99 Million |
| Operating Income | -15.56 Million | -16.67 Million | -31.28 Million | -187.34 Million | -74.35 Million | -48.41 Million |
| Interest Expense | 5.82 Million | 5.9 Million | 5.53 Million | 21.22 Million | 5.47 Million | 5.11 Million |
| Income Tax Expense | 656 Thousand | 363 Thousand | 6.64 Million | -20.32 Million | -16.38 Million | -6.54 Million |
| Earnings before Tax | -22.62 Million | -20.73 Million | -38.31 Million | -206.58 Million | -77.96 Million | -52.02 Million |
| Net Income | -23.27 Million | -21.09 Million | -44.95 Million | -186.26 Million | -61.58 Million | -45.47 Million |
| Earnings Per Share Basic | -0.06 | -0.06 | -0.12 | - | -0.17 | -0.13 |
| Earnings Per Share Diluted | -0.06 | -0.06 | -0.12 | - | -0.17 | -0.13 |
| Weighted Average Shares Outstanding | 379.42 Million | 376.33 Million | 378.72 Million | 367.45 Million | 372.47 Million | 363.16 Million |
| Weighted Average Shares Outstanding (Diluted) | 379.42 Million | 376.33 Million | 378.72 Million | 367.45 Million | 372.47 Million | 363.16 Million |
| Gross Margin | 0.25 | 0.24 | 0.22 | 0.21 | 0.29 | 0.28 |
| EBIT Margin | 0.01 | 0.02 | -0.03 | - | -0.21 | -0.11 |
| Profit Margin | -0.07 | -0.07 | -0.16 | -0.18 | -0.23 | -0.18 |
| EBITDA | 3.03 Million | 5.88 Million | -9.07 Million | - | -54.73 Million | -28.9 Million |
| Earnings Before Tax Margin | -0.05 | -0.06 | -0.11 | -0.18 | -0.28 | -0.19 |
600511
6730
IGEN
BOXE
9127
GWA